Inventor
LI XIAOKAI
US42 patents
⚠️ This page may combine multiple inventors who share the name “LI XIAOKAI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
APPLE INC
29 patentsUS11598985B1Mar 7, 2023
Systems with adjustable window transmission and haze
APPLE INC4 citations75
US10496164B2Dec 3, 2019
Electronic device with adjustable reflective display
APPLE INC2 citations73
US9904502B2Feb 27, 2018
Dual display equipment with enhanced visibility and suppressed reflections
APPLE INC4 citations73
US11119624B2Sep 14, 2021
Dynamic image stabilization using motion sensors
APPLE INC3 citations72
US10971086B2Apr 6, 2021
Pulsed backlight systems and methods
APPLE INC5 citations72
US10943959B1Mar 9, 2021
Display device with a light modulating layer
APPLE INC2 citations72
US11778858B1Oct 3, 2023
Electronic device displays having microlenses
APPLE INC2 citations71
US11754886B1Sep 12, 2023
Pixel layouts for electronic device displays
APPLE INC2 citations71
US11232745B2Jan 25, 2022
Multi-frame buffer for pixel drive compensation
APPLE INC2 citations71
US11693279B1Jul 4, 2023
Adjustable windows
APPLE INC3 citations70
US10991330B1Apr 27, 2021
Split-screen driving of electronic device displays
APPLE INC3 citations70
US12007639B2Jun 11, 2024
Systems with adjustable window transmission and haze
APPLE INC0 citations62
US11927864B2Mar 12, 2024
Optical systems having fLCOS display panels
APPLE INC0 citations62
US11804197B1Oct 31, 2023
Optical systems having overdriven fLCOS display panels
APPLE INC0 citations62
US11762197B2Sep 19, 2023
Display systems with geometrical phase lenses
APPLE INC0 citations62
US11081069B2Aug 3, 2021
Data rendering and driving of electronic device displays
APPLE INC0 citations62
US12405502B2Sep 2, 2025
Pixel layouts for electronic device displays
APPLE INC0 citations60
US11922867B1Mar 5, 2024
Motion corrected interleaving
APPLE INC0 citations60
US11605330B1Mar 14, 2023
Mitigation of tearing from intra-frame pause
APPLE INC1 citations60
US12090821B1Sep 17, 2024
Systems with adjustable window transmission
APPLE INC0 citations59
US11796872B1Oct 24, 2023
Optical systems with pixel shifting structures
APPLE INC0 citations59
US10460702B2Oct 29, 2019
Display pixel overdrive systems and methods
APPLE INC1 citations56
US11822083B2Nov 21, 2023
Display system with time interleaving
APPLE INC0 citations52
US12535708B2Jan 27, 2026
Optical systems having polarization recycling structures
APPLE INC0 citations51
US10304416B2May 28, 2019
Display overdrive systems and methods
APPLE INC0 citations51
US11822191B2Nov 21, 2023
Display system with localized optical adjustments
APPLE INC0 citations50
US11521563B2Dec 6, 2022
Techniques to compensate for flicker at low refresh rates
APPLE INC0 citations50
US10866458B2Dec 15, 2020
Electronic device display with a backlight and control circuitry that corrects pixel data to reduce transition artifacts
APPLE INC0 citations50
US11829039B1Nov 28, 2023
Optical systems with green-heavy illumination sequences for fLCOS display panels
APPLE INC0 citations49
ARROWHEAD PHARMACEUTICALS INC
8 patentsUS11597701B2Mar 7, 2023
Integrin ligands and uses thereof
ARROWHEAD PHARMACEUTICALS INC2 citations68
US12582718B2Mar 24, 2026
Integrin targeting ligands and uses thereof
ARROWHEAD PHARMACEUTICALS INC0 citations60
US11912997B2Feb 27, 2024
RNAi agents for inhibiting expression of Superoxide Dismutase 1 (SOD1), compositions thereof, and methods of use
ARROWHEAD PHARMACEUTICALS INC0 citations59
US12551569B2Feb 17, 2026
RNAi agents for inhibiting expression of microtubule associated protein tau (MAPT), compositions thereof, and methods of use
ARROWHEAD PHARMACEUTICALS INC0 citations56
US12378558B2Aug 5, 2025
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutical compositions thereof, and methods of use
ARROWHEAD PHARMACEUTICALS INC0 citations56
US11845937B2Dec 19, 2023
RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use
ARROWHEAD PHARMACEUTICALS INC1 citations55
US12221610B2Feb 11, 2025
RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions thereof, and methods of use
ARROWHEAD PHARMACEUTICALS INC0 citations50
US12503696B2Dec 23, 2025
RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmaceutical compositions thereof, and methods of use
ARROWHEAD PHARMACEUTICALS INC0 citations46